Takara Bio Inc operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Takara Bio Inc with three other
companies in this sector in Japan:
Sosei Group Corporation
sales of 8.15 billion Japanese Yen [US$73.20 million]
of which 98%
was Overseas Pharmaceutical Business),
Shin Nippon Biomedical Laboratories Ltd
(14.75 billion Japanese Yen [US$132.46 million]
of which 80%
was Pre-Clinical Business), and
Morishita Jintan Co., Ltd.
(10.43 billion Japanese Yen [US$93.68 million]
of which 63%
was Health Care Business).
Takara Bio Inc reported sales of ¥29.73 billion (US$266.97 million)
March of 2016.
increase of 14.5%
versus 2015, when the company's sales were ¥25.97 billion.
Sales at Takara Bio Inc have increased during each of the previous five years
(and since 2011, sales have increased a total of 59%).
Sales of Bio Support saw an increase
15.8% in 2016, from
¥23.59 billion to ¥27.32 billion.